@FiercePharma: Flu expert warns against USDA move to build bird flu vaccine stockpile. Article | Follow @FiercePharma
@CarlyHFierce: @RepCummings to Shkreli: "To claim that a 50% discount after a 5,000% increase is a 'price cut' is Orwellian double-speak." | Follow @CarlyHFierce
> The U.K.'s cost watchdogs have changed their mind on Novartis' ($NVS) myeloma med Farydak, recommending the drug after initially rejecting it for NHS use earlier this year. Report
> Teva ($TEVA), which has agreed to purchase Allergan's ($AGN) generics unit for $40.5 billion, has priced its public offerings of American depositary shares and mandatory convertible preferred shares. Release
> A report raises concerns about drug company employees doing health screenings at "health camps" in India where they hand out free medications. Story
> The incentives Novo Nordisk ($NVO) will get from North Carolina for investing $1.8 billion into a plant there could exceed $130 million. Story
> AstraZeneca ($AZN) will close an API plant in Bengaluru, India. Report
Medical Device News
@FierceMedDev: ICYMI yesterday: Syneron Medical bogged down with slumping sales for ultrasound fat-zapping device. Article | Follow @FierceMedDev
@VarunSaxena2: ICYMI from FierceDrugDelivery: AstraZeneca begins dosing in trial of its Bind-partnered cancer candidate. Story | Follow @VarunSaxena2
@EmilyWFierce: Check out this week's Dx Digest, featuring liquid biopsy news from Guardant Health and Circulogene Theranostics. Report | Follow @EmilyWFierce
> Novartis weighs sale of contact lens business as Alcon unit struggles to chart growth. More
> U.K.'s NHS funds 1,000+ patient trial of a minimally invasive artificial lung. Story
Biotech News
@FierceBiotech: Q&A: Philips on what's next after the first year of HealthTech. More from FierceMedicalDevices | Follow @FierceBiotech
@JohnCFierce: This week we've been seeing the venture cash flowing. Bodes well for lots more action in 2016. | Follow @JohnCFierce
> True North adds crossover investors in its $40M Series C. Article
> Kuros to merge with Cytos to gain entry to the Swiss Stock Exchange. Report
> FierceBiotech Radio on Gilead's maxed-out revenue and BioMarin's FDA struggles. More | Subscribe
CRO News
> Medidata reaches into South Korea with a CRO partnership. News
> Parexel revamps its trial management system for drugmakers large and small. Report
> INC's financiers bank another $272M in the IPO afterglow. More
> Survey: CRO employee turnover soars amid an industry boom. Story
> Quotient Clinical snapped up by Gillings-founded buyout firm. Article
Pharma Manufacturing News
> Wockhardt says U.K. regulatory agency issued GMP certificate to troubled Chikalthana plant. News
> EU agency gives Baxalta green light to begin manufacturing two plasma-based therapies. Story
> Radiopharmaceutical manufacturer Iason Italia hit with noncompliance report. Article
> FDA cites two Endo subsidiaries for product recalls. Report
> Danaher acquires German quality inspection firm Laetus for undisclosed price. Item
Pharma Asia News
> India's GVK Bio gets infusion of cash from ChrysCapital. Item
> Generic drugs face April 2016 price caps in Japan. More
> Ascletis gets $20M from Goldman in race to China HCV approval. Report
> Singapore researchers close in on 'liquid biopsy' to track cancer progress, treatment. Story
> BMJ: Drugmakers get quid pro quo for participation in Indian health camps. Article
And Finally... Allergan CEO Brent Saunders, whose Ireland-based company just agreed to merge with Pfizer ($PFE), says his father gave him a hard time at Thanksgiving dinner for helping the pharma giant dodge higher U.S. taxes. More